Patient Journey & QoL Research: Prostate Cancer Survey
A multi-country patient research study exploring treatment pathways, patient experiences and QoL in prostate cancer across 3 countries
Challenges
Different Diagnosis Pathways
Diagnosis varies across countries, with differences in screening and symptom-led diagnosis. This makes cross-country patient journeys difficult to compare.
Fragmented Care Pathways
Healthcare systems shape specialist involvement and treatment pathways. This can lead to different patient experiences across countries.
Treatment Misconceptions
Patients often have negative views of treatments they have not received. This may influence treatment expectations, decision-making and QoL.
Objectives & Endpoints
Map Patient Journeys
Compare diagnosis, treatment pathways and therapy sequences across non-metastatic and metastatic patients in the US, UK and Germany.
Assess Quality of Life
Measure patient-reported QoL and identify the clinical and demographic factors affecting their well-being.
Understand Patient Perspectives
Assess trust, treatment satisfaction and perceptions of different therapies.
Our Approach
Digital Patient Survey
Developed a large-scale online survey with academic experts and patient advocacy groups. The adaptive survey captured patient experiences across the full treatment journey.
Multi-Channel Recruitment
Recruited patients through social media, Google search and patient advocacy networks across three countries.
Targeted Cohort Analysis
Used adaptive routing to capture therapy-specific insights across key patient subgroups.
Key Findings
Treatment Patterns Differ: Prostatectomy was most common in the US (57.4%) and Germany (71.3%), while radiotherapy led in the UK (47.6%).
QoL Driven by Disease Burden: Overall QoL was similar across countries, but lower among patients with metastatic disease or multiple comorbidities.
Trust Follows Care Models: Patients reported highest trust in their main treating specialists, reflecting country-specific healthcare structures.
Business Impact & Outcomes
Identified Patient Needs: Highlighted the key clinical factors linked to poorer QoL, helping identify where patient education and support are most needed.
Supported Regional Strategies: Provided evidence on how healthcare systems influence diagnosis, specialist involvement and treatment pathways across countries.
Generated Scientific Evidence: Produced robust patient-reported data supporting multiple scientific publications and conference presentations.
*Campaign Days Refers to the number of days between the first and last day of survey completions
**Survey Completers include 12,804 non-metastatic and 3,020 metastatic patients